300 related articles for article (PubMed ID: 21787293)
1. Anabolic effects of intermittent PTH on osteoblasts.
Greenfield EM
Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
[TBL] [Abstract][Full Text] [Related]
2. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
Esbrit P; Alcaraz MJ
Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
[TBL] [Abstract][Full Text] [Related]
5. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.
Locklin RM; Khosla S; Turner RT; Riggs BL
J Cell Biochem; 2003 May; 89(1):180-90. PubMed ID: 12682918
[TBL] [Abstract][Full Text] [Related]
6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
8. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
9. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
10. Different duration of parathyroid hormone exposure distinctively regulates primary response genes Nurr1 and RANKL in osteoblasts.
Choi H; Magyar CE; Nervina JM; Tetradis S
PLoS One; 2018; 13(12):e0208514. PubMed ID: 30576321
[TBL] [Abstract][Full Text] [Related]
11. [Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].
Ogata N; Kawaguchi H
Clin Calcium; 2007 Dec; 17(12):1843-9. PubMed ID: 18057659
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
Goltzman D
Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
[TBL] [Abstract][Full Text] [Related]
13. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
Wang Y; Qin QH; Kalyanasundaram S
Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
[TBL] [Abstract][Full Text] [Related]
14. [Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment].
Kaji H
Clin Calcium; 2007 Dec; 17(12):1836-42. PubMed ID: 18057658
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone - a bone anabolic and catabolic agent.
Poole KE; Reeve J
Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
[TBL] [Abstract][Full Text] [Related]
17. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss.
Lewis JW; Frost K; Neag G; Wahid M; Finlay M; Northall EH; Abudu O; Kemble S; Davis ET; Powell E; Palmer C; Lu J; Rainger GE; Iqbal AJ; Chimen M; Mahmood A; Jones SW; Edwards JR; Naylor AJ; McGettrick HM
Cell Rep Med; 2024 May; 5(5):101574. PubMed ID: 38776873
[TBL] [Abstract][Full Text] [Related]
19. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
20. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
Komarova SV
Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
